Introduction: There is a need for clinically administered instruments capable of detecting executive dysfunction in dementia. Objective: The translation and validation of Executive Battery 25 (EB25) and a short version for screening of executive dysfunction in dementia. Methods: The original battery was translated and validated using convergent and divergent correlation in 66 mild dementia patients (CDR 1) matched with 66 controls. EB25 consists of 25 items which detect executive dysfunction. Convergent correlation was made with 7 tests assessing executive dysfunction, the Frontal Systems Behavior Scale (FrSBe) and Disability Fast Assessment Scale. Results: Patients had higher scores than controls and correlated with the Stroop Test, verbal...
Background: The prevalence of cognitive impairment (CI) will double in the next 20 years, making ear...
Background: “Forgetfulness” is frequent in normal aging and characteristic of the early stages of de...
International audienceThe frequency of executive disorders in mild-to-moderate Alzheimer disease (AD...
Resumen: Introducción: Se necesitan instrumentos que detecten disfunción ejecutiva en demencias y q...
Introduction: Addenbrooke's Cognitive Examination is a screening test used to diagnose dementia. The...
Introducción: Los pacientes con demencia son considerados conductores de alto riesgo. Sin embargo, u...
Background: The Addenbrooke's Cognitive Examination Revised (ACE-R) is an improved version of the ea...
Objective: To validate a Spanish version of the TYM, a self-administered cognitive screening test de...
Introduction and objectives: The Relevant Outcome Scale for Alzheimer's Disease (ROSA) is a useful t...
Background: Alzheimer’s disease (AD) is a neurodegenerative disease that causes a gradual loss of co...
Resumen: Objetivos: El Rivermead Behavioural Memory Test (RBMT) es una batería ecológica breve que ...
Objetivos: O Acidente Vascular Cerebral (AVC) potencia o desenvolvimento de disfunção executiva, con...
Artículo de publicación ISIObjectives: To develop the Test Your Memory (TYM)—Spanish version (TYM-S)...
Background: The Addenbrooke’s Cognitive Examination III (ACE-III), an adaptation of the ACE cogni...
Introduction: The Frontotemporal Dementia Rating Scale (FTD-FRS) is a tool designed to aid with clin...
Background: The prevalence of cognitive impairment (CI) will double in the next 20 years, making ear...
Background: “Forgetfulness” is frequent in normal aging and characteristic of the early stages of de...
International audienceThe frequency of executive disorders in mild-to-moderate Alzheimer disease (AD...
Resumen: Introducción: Se necesitan instrumentos que detecten disfunción ejecutiva en demencias y q...
Introduction: Addenbrooke's Cognitive Examination is a screening test used to diagnose dementia. The...
Introducción: Los pacientes con demencia son considerados conductores de alto riesgo. Sin embargo, u...
Background: The Addenbrooke's Cognitive Examination Revised (ACE-R) is an improved version of the ea...
Objective: To validate a Spanish version of the TYM, a self-administered cognitive screening test de...
Introduction and objectives: The Relevant Outcome Scale for Alzheimer's Disease (ROSA) is a useful t...
Background: Alzheimer’s disease (AD) is a neurodegenerative disease that causes a gradual loss of co...
Resumen: Objetivos: El Rivermead Behavioural Memory Test (RBMT) es una batería ecológica breve que ...
Objetivos: O Acidente Vascular Cerebral (AVC) potencia o desenvolvimento de disfunção executiva, con...
Artículo de publicación ISIObjectives: To develop the Test Your Memory (TYM)—Spanish version (TYM-S)...
Background: The Addenbrooke’s Cognitive Examination III (ACE-III), an adaptation of the ACE cogni...
Introduction: The Frontotemporal Dementia Rating Scale (FTD-FRS) is a tool designed to aid with clin...
Background: The prevalence of cognitive impairment (CI) will double in the next 20 years, making ear...
Background: “Forgetfulness” is frequent in normal aging and characteristic of the early stages of de...
International audienceThe frequency of executive disorders in mild-to-moderate Alzheimer disease (AD...